Skip to main content
Clinical Trials/ACTRN12623000982617
ACTRN12623000982617RecruitingUnknown

Impact of high-frequency jet ventilation (HFJV) on ablation catheter stability and duration of pulmonary vein electrical isolation procedures for atrial fibrillation in adults

Adrien Maseri0 sites150 target enrollmentStarted: September 8, 2023Last updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Recruiting
Sponsor
Enrollment
150

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • Age > 18 years
  • Documentation of atrial fibrillation for which an indication for ablation has been made by a cardiologist and accepted by the patient
  • Written agreement to the research protocol

Exclusion Criteria

  • - Extreme COPD (GOLD 4)
  • - Lung transplant patients
  • - Patients with cystic fibrosis, primary ciliary dyskinesia or other conditions involving mucociliary escalator fragility
  • - Corrected complex congenital heart disease
  • - Morbid obesity (BMI >40)
  • - Patient allergic to soy ( contraindicating the use of propofol necessary for induction and maintenance of anaesthesia in high frequency jet-ventilation

Investigators

Sponsor
Adrien Maseri

Similar Trials